3 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18094151 | LIGHT INHIBITORS FOR SCLERODERMA AND SKIN FIBROTIC DISEASE TREATMENT | WEN, SHARON X | 1641 | Final Rejection | Jan 06, 2023 |
| 17048059 | MODULATING IMMUNE RESPONSE VIA TARGETING OF OLFACTORY RECEPTOR ACTIVITY | CHERNYSHEV, OLGA N | 1675 | Non-Final OA | Oct 15, 2020 |
| 16765783 | USE AND PRODUCTION OF ENGINEERED IMMUNE CELLS TO DISRUPT NFAT-AP1 PATHWAY TRANSCRIPTION FACTORS | GONZALES, JOSEPHINE MARIA | 1631 | Non-Final OA | May 20, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial